Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the “Real World”? A Systematic Review – Beyond the Abstract
prostate cancer, metastatic hormone sensitive prostate cancer (mHSPC), Metastatic Hormone-sensitive Prostate Cancer Treatment, Docetaxel, Novel Hormonal Therapy (NHT), enzalutamide, apalutamide, abiraterone, androgen deprivation therapy (ADT).